Colon Cancer

In this episode, Guido Baechler discusses the pandemic’s impact on healthcare and preventative health, personalizing cancer care after diagnosis and more.

In a Healio video exclusive, Chris Evans, president of the Colon Cancer Coalition and Healio’s 2021 Patient Voice Disruptive Innovator, shares updates on the organization’s recent accomplishments and future plans.

CHICAGO — Circulating tumor DNA analysis safely reduced adjuvant chemotherapy use without compromising recurrence-free survival among patients with stage II colon cancer, according to results of the randomized phase 2 DYNAMIC trial.

Colorectal cancer is the third leading cause of cancer-related deaths in the United States, for both men and women, and across the entire population represents the second most common cause of cancer deaths and diagnoses.

In partnership with the Colon Cancer Coalition, Salix Pharmaceuticals launched the Faces of Blue campaign to raise awareness about the importance of colorectal cancer screening and early detection.

Memorial Sloan Kettering Cancer Center paused a phase 1 trial for a chimeric antigen receptor T-cell therapy to investigate the death of a patient who received the treatment. It was the top story in hematology/oncology last week.

Consumption of unprocessed red or processed meat did not impact risk for colon cancer recurrence or mortality, according to a prospective cohort study of patients with stage III colon cancer published in JAMA Network Open.

Exact Science announced its second-generation Cologuard test performance data, according to a company press release.

In a Healio video exclusive, John Inadomi, MD, president of the American Gastroenterological Association, outlined the Biden administration’s new guidance requiring private insurers to cover the cost of follow-up colonoscopy.

LAS VEGAS – Obesity was an independent risk factor for the development of colorectal cancer among patients who underwent weight loss surgery or who were on weight loss medication, according to a presentation.